# Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant

> **NCT06928779** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 19 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Dazucorilant

## Key facts

- **NCT ID:** NCT06928779
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2024-12-09
- **Final completion:** 2024-12-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06928779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06928779, "Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06928779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*